Biologic effects of and clinical disorders caused by nonprotein amino acids

Medicine

Volumn 79, Issue 2, 2000, Pages 80-89

  Rubenstein, Edward ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; 2 AMINO 3 METHYLAMINOPROPIONIC ACID; 3 OXALYLAMINOALANINE; AMINO ACID; AZETIDINE 2 CARBOXYLIC ACID; CANAVANINE; COPRINE; HEPTANOIC ACID DERIVATIVE; HYPOGLYCINE A; MIMOSINE; TRYPTOPHAN;

AMINO ACID ANALYSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DIETARY INTAKE; FOOD INTAKE; FRUIT; HUMAN; INTOXICATION; LEGUME; NEUROTOXICITY; PHYTOCHEMISTRY; PLANT SEED; PRIORITY JOURNAL; PROTEIN STRUCTURE;

AMINO ACIDS; ANIMALS; DIET FADS; DIETARY SUPPLEMENTS; FABACEAE; FRUIT; HUMANS; MOLECULAR STRUCTURE; NUTS; PLANTS, MEDICINAL; SEEDS;

EID: 0034037157     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-200003000-00002     Document Type: Article

References (98)

1. Akeson AL, Woods CW, Hsieh LC, Bohnke RA, Ackerman BL, Chan KY, Robinson JL, Yanofsky SD, Jacobs JW, Barrett RW, Bowlin TL. AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J Biol Chem 271: 30517-23, 1996.
2. WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ 7: 893-901, 1996.
3. Anonymous. Eosinophilia-myalgia syndrome - New Mexico. MMWR Morb Mortal Wkly Rep 38: 766-67, 1989.
4. Anonymous. Eosinophilia-myalgia syndrome and L-tryptophan-containing products - New Mexico, Minnesota, Oregon, and New York, 1989. MMWR Morb Mortal Wkly Rep 38: 785-88, 1989.
5. Anonymous. Update: Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome. MMWR Morb Mortal Wkly Rep 39: 589-91, 1990.
6. Anthony EW, Nevins ME. Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test. Eur J Pharmacol 250: 317-24, 1993.
7. Bailie JR, Walker B, Nelson J, Murphy RF. Synthesis of a cyclic analogue of the C-loop region of epidermal growth factor, containing 1-aminocyclopropane-1-carboxylic acid. Int J Pept Protein Res 43: 225-29, 1994.
8. Bardana EJ Jr, Malinow MR, Houghton DC, McNulty WP, Wuepper KD, Parker F, Pirofsky B. Diet-induced systemic lupus erythematosus (SLE) in primates. Am J Kidney Dis 6: 345-52, 1982.
9. Bardana EJ, Malinow MR, Craig S, McLaughlin P. Cross-reacting antibody (AB) to alfalfa seed and deoxyribonucleic acid (DNA) in SLE [abstract]. J Allergy Clin Immunol 71: 102, 1983.
10. Bell EA. Canavanine and related compounds in Leguminosae. Biochem J 70: 439-86, 1958.
11. Berggren D, Frenz D, Galinovic-Schwartz V, Van de Water TR. Fine structure of extracellular matrix and basal laminae of two types of abnormal collagen production: L-proline analog-treated otocyst cultures and disproportionate micromelia XX (Dmm/Dmm) mutants. Hear Res 107: 125-35, 1997.
12. Botella JR, Arteca RN, Frangos JA. A mechanical strain-induced 1-aminocyclopropane-1-carboxylic acid synthase gene. Proc Natl Sci U S A 92: 1595-98, 1995.
13. Burroughs LF. Amino acids. In: Hulme AC, ed. The biochemistry of fruits and their products. Vol 1. London: Academic Press, pp 119-44, 1970.
14. Buss WC, Stepanek J, Bankhurst AD, Mayeno AN, Pastuszyn A, Peabody D. EBT, a tryptophan contaminant associated with eosinophilia myalgia syndrome, is incorporated into proteins during translation as an amino acid analogue. Autoimmunity 25: 33-45, 1996.
15. Carrington MJ, Fornieri D, Bartlet CP, Heale G, Levene CI. Biochemical and ultrastructural study of the effects of proline analogues on collagen synthesis in 3T6 fibroblasts. J Pharm Pharmacol 37: 794-801, 1985.
16. Cho MI, Garant PR, Effects of L-azetidine-2-carboxylic acid on matrix secretion and Golgi structure in fibroblasts and osteoblasts of the mouse. Anat Rec 212: 232-38, 1985.
17. Christie GS, Wilson M, Hegarty MP. Effects on the liver in the rat of ingestion of Indigofera spicata, a legume containing an inhibitor of arginine metabolism. J Pathol 117: 195-205, 1975.
18. Eizirik DL, Kisby GE. Cycad-toxin induced damage of rodent and human pancreatic beta-cells. Biochem Pharmacol 31: 355-65, 1995.
19. Fowden L, Richmond MH. Replacement of proline by azetidine-2-carboxylic acid during biosynthesis of protein. Biochim Biophys Acta 71: 459-61, 1963.
20. Garlepp MJ. Immunogenetics of inflammatory myopathies. Baillieres Clin Neurol 2: 579-97, 1993.
21. Gelpi S, Sontheimer EJ, Rodriguez-Sanchez JL. Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion. Proc Natl Acad Sci U S A 89: 9739-43, 1992.
22. Golding J, Foster-Williams K, Coard K, Ashley D. A cluster of central nervous system defects in Jamaica. Hum Exp Toxicol 9: 13-16, 1990.
23. Gorospe M, Wang X, Guyton KZ, Holbrook NJ. Protective role of p21(Waf1/Cipl) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol Cell Biol 16: 6654-60, 1996.
24. Hammond AC. Leucaena toxicosis and its control in ruminants. J Anim Sci 73: 1487-92, 1995.
25. Hammond AC, Allison MJ, Williams MJ, Prine GM, Bates DB. Prevention of leucaena toxicosis of cattle in Florida by ruminal inoculation with 3-hydroxy-4-(1H)-pyridone-degrading bacteria. Am J Vet Res 50: 2176-80, 1989.
26. Hegarty MP, Kelly WR, McEwan D, Williams OJ, Cameron R. Hepatotoxicity to dogs of horse meat contaminated with indospicine. Aust Vet J 65: 337-40, 1988.
27. Heppenstall PA, Fleetwood-Walker SM. The glycine site of the NMDA receptor contributes to the neurokinin-1 receptor agonist facilitation of NMDA receptor agonist-evoked activity in rat dorsal horn neurons. Brain Research 744: 235-45, 1997.
28. Herbert V, Kasdan TS. Alfalfa, vitamin E, and autoimmune disorders. Am J Clin Nutr 90: 639-42, 1994.
29. Hey C, Boucher JL, Vadon-Le Goff S, Ketterer G, Wessler I, Racke K. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase. Br J Pharmacol 121: 395-400, 1997.
30. Hill RH Jr, Caudill SP, Philen RM, Bailey SL, Flanders WD, Driskell WJ, Kamb ML, Needham LL, Sampson EJ. Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome. Arch Environ Contam Toxicol 25: 134-42, 1993.
31. Hood WF, Compton RP, Monahan JB. N-methyl-D-aspartate recognition site ligands modulate activity at the coupled glycine recognition site. J Neurochem 54: 1040-46, 1990.
32. Hughes TA, Cook PR. Mimosine arrests the cell cycle after cells enter S-phase. Exp Cell Res 222: 275-80, 1996.
33. Ikeda Y, Tanaka K. Selective inactivation of various acyl-CoA dehydrogenases by (methylenecyclopropyl) acetyl-CoA. Biochim Biophys Acta 1038: 216-21, 1990.
34. Ingbar D, Folkman J. Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59: 44-51, 1988.
35. Jones RJ, Lowry JB. Australian goats detoxify the goitrogen 3-hydroxy-4-(1H) pyridone (DHP) after rumen infusion from an Indonesia goat. Experientia 40: 1435-36, 1984.
36. Jonsson M, Lindquist NG, Ploen L, Ekvarn S, Kronevi T. Testicular lesions of coprine and benzcoprine. Toxicology 12: 89-100, 1979.
37. Kaljeta RF, Hamlin JL. The dual effect of mimosine on DNA replication. Exp Cell Res 231: 173-83, 1997.
38. Kaufman LD. Chronicity of the eosinophilia-myalgia syndrome. A reassessment after three years. Arthritis Rheum 37: 84-87, 1994.
39. Kolesnikov YA, Maccechini ML, Pasternak GW. 1-aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci 55: 1393-98, 1994.
40. Krude T. Mimosine arrests proliferating human cells before onset of DNA replication in a dose-dependent manner. Exp Cell Res 247: 148-59, 1999.
41. Kulp KS, Green SL, Vulliet PR. Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. Exp Cell Res 229: 60-68, 1996.
42. Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. Neurology 4: 355-78, 1954.
43. Lalande MA. Reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp Cell Res 186: 332-39, 1990.
44. Levenson V, Hamlin JL. A general protocol for evaluating the specific effects of DNA replication inhibitors. Nucleic Acids Res 21: 3997-4004, 1993.
45. Li CJ, Brownson DJ, Mabry TJ, Perera C, Bell EA. Nonprotein amino acids from seeds of Cycas circinalis and Phaseolus vulgaris. Phytochemistry 42: 443-45, 1996.
46. Lin H, Chang YF, Liu TY, Wu CS, Chi CW. Submicromolar paclitaxel induces apoptosis in human gastric cancer cells at early G1 phase. Anti-cancer Res 18: 3443-49, 1998.
47. Lin H, Falchetto R, Mosca PJ, Shabanowitz J, Hunt DF, Hamlin JL. Mimosine targets serine hydroymethyltransferase. J Biol Chem 271: 2548-56, 1996.
48. Love LA, Rader JI, Crofford LJ, Raybournc RB, Principato MA, Page SW, Trucksess MW, Smith MJ, Dugan EM, Turner ML, Zelazowsky E, Zelazowsky P, Sternberg EM. Pathological and immunological effects of ingesting L-tryptophan and 1,1′-ethylidenebis (L-tryptophan) in Lewis rats. J Clin Invest 91: 804-11, 1993.
49. Lubec G, Pollak A, Coradella H, Aschinger H, Wagendristl A, Bangert H, Seifert K, Ratzenhofer E. Structural changes of hair after incorporation of the proline analogue L-azetidine-2-carboxylic acid. A model of hair disease by alteration of primary structure. Wien Klin Wochenschr 97: 401-3, 1985.
50. Malinow MR, Bardana EJ Jr, Goodnight SH Jr. Pancytopenia during ingestion of alfalfa seeds [letter]. Lancet 1: 615, 1981.
51. Malinow MR, Bardana EJ Jr, Pirofsky B, Craig S, McLaughlin P. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: Role of a nonprotein amino acid. Science 216: 415-17, 1982.
52. Marvizon JC, Lewin AH, Skolnick P. 1-aminocyclopropane-1-carboxylic acid: A potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex. J Neurochem 52: 992-94, 1989.
53. Michelangeli C, Vargas RE. L-canavanine influences feed intake, plasma basic amino acid concentrations and kidney arginase activity in chicks. J Nutr 124: 1081-87, 1994.
54. Michelot D. Poisoning by Coprinus atramentarius. Nat Toxins 1: 73-80, 1992.
55. Miyachi K, Takano S, Mimori T, Yamagata H, Mita S, Matsuoka Y, Irimajiri S, Tani K, Akizuki M, Homma M. A novel autoantibody reactive with a 48 kDa tRNA associated protein in patients with scleroderma. J Rheumatol 18: 373-78, 1991.
56. Morton RL, David H, O'Connor PM, Bustin M. Chromosomal proteins HMG-14 and HMG-17 are synthesized throughout the S-phase in Burkitt's lymphoma. Biochem Biophys Res Commun 222: 368-73, 1996.
57. Naeger LK, Good-win EC, Hwang ES, DeFilippis RA, Zhang H, DiMaio D. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p-53-negative HT-3 cervical carcinoma cells and accumulation of hypophosphorylated retinoblastoma protein. Cell Growth Differ 10: 413-22, 1999.
58. Nichols RC, Binder J, Pai SI, Ge Q, Targoff IN, Plotz PH, Liu P. Assignment of two human autoantigen genes: Isoleucyl-tRNA synthetase locates to 9q21 and lysyl-tRNA synthetase locates to 16q23-q24. Genomics 36: 210-13, 1996.
59. Norrby K. The proline analogue L-azetidine-2-carboxylic acid modifies the neovascularization pattern by inhibiting branching or tortuosity and stimulating spatial expansion in the rat mesentery. Int J Microcirc Clin Exp 12: 119-29, 1993.
60. Oh CH, Jung-Han K, Kyoung-Rae K, Mabry TK. Rapid gas Chromatographic screening of edible seeds, nuts, and beans for non-protein and protein amino acids. J Chromatogr A 708: 131-41, 1995.
61. Ohosone Y, Ishida M, Takahashi Y, Matsumura M, Hirakata M, Kawahara Y, Nishikawa T, Mimori T. Spectrum and clinical significance of autoantibodies against transfer RNA. Arthritis Rheum 41: 1625-31, 1998.
62. Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda MD), 1999. World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/.
63. Palekar RS, Dastur DK. Cycasin content of Cycas circinalis. Nature 206: 1363-65, 1965.
64. Parratt JR. Nitric oxide in sepsis and endotoxaemia. J Antimicrob Chemother 41(Suppl A): 31-39, 1998.
65. Pass MA, Arab H, Pollitt S, Hegarty MP. Effects of the naturally occurring arginine analogues indospicine and canavanine on nitric oxide mediated functions in aortic endothelium and peritoneal macrophages. Nat Toxins 4: 135-40, 1996.
66. Paul IA, Trullas R, Skolnick P, Nowak G. Down-regulation of cortical beta-adrenoreceptors by chronic treatment with functional NMDA antagonists. Psychopharmacology 106: 285-87, 1992.
67. Ram JJ, Atreja PP, Chopra RC, Chhabra A. Mimosine degradation in calves fed a sole diet of Leucaenia leucocephalia. Trop Anim Health Prod 26: 199-206, 1994.
68. Rao SLN, Adiga PR, Sarma PS. The isolation and characterization of β-N-oxalyl-L-α, β-diamino-proprionic acid. A neurotoxin from the seeds of Lathyrus sativus. Biochemistry 3: 432-36, 1964.
69. Rao TS, Cler JA, Compton RP, Emmett MR, Mick S, Sun ET, Iyengar S, Wood PL. Neuropharmacological characterization of 1-aminocyclopropane-1-carboxylate and 1-aminocyclobutane-1-carboxylate, ligands of the N-methyl-D-aspartate-associated glycine receptor. Neuropharmacology 29: 305-9, 1990.
70. Reis PJ, Tunks DA. Hegarty MP. Fate of mimosine administered orally to sheep and its effectiveness as a defleecing agent. Aust J Biol Sci 28: 495-501, 1975.
71. Roberts JL, Hayashi JA. Exacerbation of systemic lupus erythematosus associated with alfalfa ingestion [letter]. N Engl J Med 308: 1361, 1983.
72. Roland L. Amyotrophic lateral sclerosis and autoimmunity. N Engl J Med 327: 1752-53, 1992.
73. Rosenthal GA. The biological effects and mode of action of L-canavanine, a structural analogue of L-arginine. Q Rev Biol 52: 155-78, 1977.
74. Rosenthal GA, Bell EA. Naturally occurring, toxic nonprotein amino acids. In: Rosenthal GA, Janzen DH, eds. Herbivores: Their interaction with secondary plant metabolites. New York: Academic Press, pp 361-63, 1979.
75. Rosenthal GA. Purification and characterization of the higher plant enzyme L-canaline reductase. Proc Natl Acad Sci U S A 89: 1780-84, 1992.
76. Rosenthal GA. L-canaline: A potent antimetabolite and anti-cancer agent from leguminous plants. Life Sci 60: 1635-41, 1997.
77. Rubenstein E. Eosinophilia-myalgia syndrome. In: Rubenstein E, Federman DD, eds. Scientific American medicine. New York: Scientific American, pp 8:11: 6-7, 1991.
78. Saika S, Hashizume N, Okada Y. Prolyl hydroxylase inhibitor and lysyl hydroxylase inhibitor inhibit spreading of corneal epithelialization. Graefes Arch Clin Exp Ophthalmol 232: 499-502, 1994.
79. Sand R, Wiezorek JS, Moore PS, Chang Y. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol 73: 1438-46, 1999.
80. Schwartz RS. Autoimmunity and autoimmune disease. In: Paul WE, ed. Fundamental immunology. New York: Academic Press, pp 1033-97, 1997.
81. Shirai M, Watanabe S, Nishioka M. Autoantibody specific for transfer ribonucleic acid (tRNA) in patients with autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepato-Gastroenterology 38: 543-46, 1991.
82. Silver RM, Ludwicka A, Hampton M, Ohba T, Bingel SA, Smith T, Harley RA, Maize J, Heyes MP. A murine model of the eosinophilia-myalgia syndrome induced by 1,1′-ethylidenebis (L-tryptophan). J Clin Invest 93: 1473-80, 1994.
83. Spencer PS, Nunn PB, Hugon J, Ludolph, AC, Ross SM, Roy DN, Robertson RC. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 237: 517-22, 1987.
84. Spencer PS, Roy DN, Ludolph A, Hugon J, Dwivedi MP, Schaumberg HH. Lathyrism: Evidence for the role of the neuroexcitatory amino acid BOAA, Lancet 2: 1066-67, 1986.
85. Stryer L. Biochemistry. 4th ed. New York: WH Freeman, pp 31-32, 1995.
86. Swaffar DS, Ang CY, Desai PB, Rosenthal GA, Thomas DA, Crooks PA, John WJ. Combination therapy with 5-fluorouracil and L-canavanine: in vitro and in vivo studies. Anti-Cancer Drugs 6: 586-93, 1995.
87. Tanaka K, Ikeda Y. Hypoglycin and Jamaican vomiting sickness. Prog Clin Biol Res 321: 167-84, 1990.
88. Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest 91: 2556-64, 1993.
89. Trebitsh T, Staub JE, O'Neill SD. Identification of a 1-amino-cyclopropane-1-carboxylic acid synthase gene linked to the female (F) locus that enhances female sex expression in cucumber. Plant Physiol 113: 987-95, 1997.
90. Tsvetkov LM, Russev GC, Anachkova BB. Effect of mimosine on DNA synthesis in mammalian cells. Cancer Res 57: 2252-55, 1997.
91. Watson GB, Lanthorn TH. Pharmacologic characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site. Neuropharmacology 29: 727-30, 1990.
92. Weiss JH, Choi DW. Slow non-NMDA receptor mediated neurotoxicity and amyotrophic lateral sclerosis. Adv Neurol 56: 311-18, 1991.
93. White MF, Vasquez J, Yang SF, Kirsch JF. Expression of apple 1-aminocyclopropane-1-carboxylate synthase in Eschericia coli: Kinetic characterization of wild-type and active-site mutant forms. Proc Natl Sci U S A 91: 12428-32, 1994.
94. White RJ, Bowes S, Hollis S, Heald J. Phytochemical database. In: Bisby FA, Buckingham J, Harborne JB, eds. Phytochemical dictionary of the leguminosae. Vol 1 and 2. London: Chapman & Hall, 1994.
95. Williamson BL, Benson LM, Tomlinson AJ, Mayeno AN, Gleich GJ, Naylor S. On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of eosinophilia-myalgia syndrome. Toxicol Lett 92: 139-48, 1997.
96. Wink M. Special nitrogen metabolism. In: Dey PM, Harborne JB, eds. Plant biochemistry. San Diego: Academic Press, pp 440-43, 1997.
97. Zagari A, Palmer KA, Gibson KD, Nemethy G, Scheraga HA. The effect of 1-azetidine-2-carboxylic acid residue on protein conformation. IV. Local substitutions in the collagen triple helix. Biopolymers 34: 51-60, 1994.
98. Zapata A, Capdevila JL, Viu E, Trullas R. 1-aminocyclopropane-carboxylic acid reduces NMDA-induced hippocampal neurodegeneration in vivo. Neuroreport 7: 397-400, 1996.